Underestimated newcomers: mid-cap biotech companies
The steadily growing importance of small and mid-cap biotech companies has not yet been fully acknowledged by financial markets.
Stay updated with breaking news from Bb Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The steadily growing importance of small and mid-cap biotech companies has not yet been fully acknowledged by financial markets.
Biotech companies that became popular with investors during the pandemic are now falling out of favour.
Investment Week’s Alex Rolandi asks Dallas Webb, portfolio manager at BB Biotech, what the future holds for biotechnology.
Biotech investors and analysts are looking to the new year with optimism following poor performance in 2021.
The pandemic has acted as a catalyst for the biotechnology and health industries, accelerating the pace at which new technologies are being adopted.